Sara Burcheri

890 total citations
15 papers, 603 citations indexed

About

Sara Burcheri is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Sara Burcheri has authored 15 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Oncology and 7 papers in Genetics. Recurrent topics in Sara Burcheri's work include Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Sara Burcheri is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Viral-associated cancers and disorders (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Sara Burcheri collaborates with scholars based in Italy, France and Ukraine. Sara Burcheri's co-authors include Luca Arcaini, Mario Lazzarino, Francesco Passamonti, Cristiana Pascutto, Emanuela Boveri, Laura Vanelli, Elisa Rumi, Matteo Giovanni Della Porta, Mario Cazzola and Daniela Pietra and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Sara Burcheri

15 papers receiving 587 citations

Peers

Sara Burcheri
Sara Burcheri
Citations per year, relative to Sara Burcheri Sara Burcheri (= 1×) peers Karin Fahl Wader

Countries citing papers authored by Sara Burcheri

Since Specialization
Citations

This map shows the geographic impact of Sara Burcheri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Burcheri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Burcheri more than expected).

Fields of papers citing papers by Sara Burcheri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Burcheri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Burcheri. The network helps show where Sara Burcheri may publish in the future.

Co-authorship network of co-authors of Sara Burcheri

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Burcheri. A scholar is included among the top collaborators of Sara Burcheri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Burcheri. Sara Burcheri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Lamure, Sylvain, Camille Carles, Philippe Quittet, et al.. (2019). Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma. JAMA Network Open. 2(4). e192093–e192093. 9 indexed citations
2.
Lamure, Sylvain, Camille Carles, Philippe Quittet, et al.. (2018). Occupational exposure to pesticides and prognosis of diffuse large B-cell lymphoma: A cohort study.. Journal of Clinical Oncology. 36(15_suppl). 1564–1564. 1 indexed citations
3.
Burcheri, Sara, et al.. (2017). Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database. Thrombosis Research. 157. 154–156. 3 indexed citations
4.
Gérard, Laurence, Jean‐Marie Michot, Sara Burcheri, et al.. (2012). Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease. Blood. 119(10). 2228–2233. 79 indexed citations
5.
Adès, Lionel, Simone Boehrer, Thomas Prébet, et al.. (2008). Efficacy and safety of lenalidomide in intermediate-2 or high-risk myelodysplastic syndromes with 5q deletion: results of a phase 2 study. Blood. 113(17). 3947–3952. 107 indexed citations
6.
Burcheri, Sara, Luca Arcaini, Matteo Giovanni Della Porta, et al.. (2007). An Insidious Presentation of Splenic Marginal Zone Lymphoma. Clinical Lymphoma & Myeloma. 7(6). 432–433. 2 indexed citations
7.
Arcaini, Luca, Sara Burcheri, Andrea Rossi, et al.. (2007). Risk of Second Cancer in Nongastric Marginal Zone B-Cell Lymphomas of Mucosa-Associated Lymphoid Tissue: A Population-Based Study from Northern Italy. Clinical Cancer Research. 13(1). 182–186. 6 indexed citations
8.
Arcaini, Luca, Paolo Bernasconi, Silvia Calatroni, et al.. (2006). Role of the molecular staging and response in the management of follicular lymphoma patients. Leukemia & lymphoma. 47(6). 1018–1022. 2 indexed citations
9.
Arcaini, Luca, Marco Paulli, Sara Burcheri, et al.. (2006). Primary nodal marginal zone B‐cell lymphoma: clinical features and prognostic assessment of a rare disease. British Journal of Haematology. 136(2). 301–304. 51 indexed citations
10.
Burcheri, Sara & Luca Arcaini. (2006). A paraumbilical lymphomatous mass. European Journal Of Haematology. 77(2). 180–180. 3 indexed citations
11.
Lazzarino, Mario, Luca Arcaini, Ester Orlandi, et al.. (2005). Immunochemotherapy with Rituximab, Vincristine and 5-Day Cyclophosphamide for Heavily Pretreated Follicular Lymphoma. Oncology. 68(2-3). 146–153. 7 indexed citations
12.
Arcaini, Luca, Francesco Passamonti, Sara Burcheri, et al.. (2005). Correlation of the FLIPI score for follicular lymphoma with period of diagnosis and type of treatment. Leukemia Research. 30(3). 277–282. 17 indexed citations
13.
Passamonti, Francesco, Elisa Rumi, Daniela Pietra, et al.. (2005). Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders. Blood. 107(9). 3676–3682. 191 indexed citations
14.
Arcaini, Luca, Ester Orlandi, Ercole Brusamolino, et al.. (2004). Combination of Rituximab, Cyclophosphamide, and Vincristine Induces Complete Hematologic Remission of Splenic Marginal Zone Lymphoma. Clinical Lymphoma. 4(4). 250–252. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026